U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT07455084) titled 'A Study to Detect the Radioactivity of 14C-SEP-380135 in Urine and Feces in Healthy Male Adults' on March 03.
Brief Summary: The purpose of the present trial is to obtain information on the absorption, distribution, metabolism, excretion and pharmacokinetics (PK) of 14C-SEP-380135 and its metabolites following a single oral dose.
Study Start Date: March 20
Study Type: INTERVENTIONAL
Condition:
Schizophrenia
Intervention:
DRUG: 14C-SEP-380135
Oral Capsule
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Disclaimer: Curated by HT Syndication....